Clinical Trial: Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria
Study Status: Completed
Recruit Status: RECRUITING
Condition: Phenylketonuria
Study Type: INTERVENTIONAL
Official Title: Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria?a Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical S
Brief Summary:
This is a randomized, double-blind, placebo-controlled, parallel-group study.A total of 15 children with phenylketonuria(PKU) age 3 to 17 years will be randomized to two groups.Experimental group of 10 children will intervene engineered probiotics (CBT102-A) for 20 days and 5 children will intervene placebo.The goal of this study is to determine whether CBT102-A is an effective and safe treatment for PKU.
Read more